IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 0.105 EUR -99.63% Market Closed

Market Cap: €8.1B

I	ImmunoGen Inc F:IMU	US
W	Wharf Holdings Ltd F:WHA	HK
B	Basf Se XBER:BAS	DE
	Aguia Resources Ltd F:5N91	AU
	Transocean Ltd NYSE:RIG	CH
C	Caixabank SA XBER:48CA	ES
A	Aptiv PLC F:D7A	IE
C	CorMedix Inc F:19KA	US
S	Steel Dynamics Inc XMUN:SD5	US
B	Bank of America Corp BMV:BAC	US

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

75% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-199% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-61%

Net Margin is Increasing

-199% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-105%

Free Cash Flow Margin is Increasing

-218% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

ROIC is Increasing

-582% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.